# I2PETHV - Imidazoline2 Binding Site in Healthy Volunteers

> **NCT02323217** · EARLY_PHASE1 · COMPLETED · sponsor: **Imperial College London** · enrollment: 20 (actual)

## Conditions studied

- Healthy Volunteers
- Alzheimer Disease
- Molecular Imaging

## Interventions

- **RADIATION:** [11C]BU99008
- **DRUG:** Idazoxan
- **DRUG:** Isocarboxazid

## Key facts

- **NCT ID:** NCT02323217
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2016-02
- **Final completion:** 2016-07
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-11-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02323217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02323217, "I2PETHV - Imidazoline2 Binding Site in Healthy Volunteers". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02323217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*